AMPICILLIN SODIUM FOR INJECTION, USP POWDER FOR SOLUTION

国: カナダ

言語: 英語

ソース: Health Canada

即購入

ダウンロード 製品の特徴 (SPC)
14-02-2020

有効成分:

AMPICILLIN (AMPICILLIN SODIUM)

から入手可能:

TEVA CANADA LIMITED

ATCコード:

J01CA01

INN(国際名):

AMPICILLIN

投薬量:

2G

医薬品形態:

POWDER FOR SOLUTION

構図:

AMPICILLIN (AMPICILLIN SODIUM) 2G

投与経路:

INTRAMUSCULAR

パッケージ内のユニット:

15G/50G

処方タイプ:

Prescription

治療領域:

AMINOPENICILLINS

製品概要:

Active ingredient group (AIG) number: 0105872012; AHFS:

認証ステータス:

APPROVED

承認日:

2014-05-21

製品の特徴

                                __________________________________________________________________________________
_AMPICILLIN SODIUM FOR INJECTION _Page 1 of 11
PRESCRIBING INFORMATION
Sterile
Pr
AMPICILLIN SODIUM FOR INJECTION
(ampicillin sodium)
USP
Antibiotic
Teva Canada Limited
30 Novopharm Court
Toronto, Ontario
Canada M1B 2K9
www.tevacanada.com
CONTROL#: 234483
Date of Revision:
February 14, 2020
________________________________________________________________________________________
_AMPICILLIN SODIUM FOR INJECTION _Page 2 of 11
_ _
Sterile
PR
AMPICILLIN SODIUM FOR INJECTION
USP
ANTIBIOTIC
ACTIONS AND CLINICAL PHARMACOLOGY
Ampicillin has a broad spectrum of bactericidal activity against many
gram-positive and gram-
negative aerobic and anaerobic bacteria. It acts through the
inhibition of cell wall mucopeptide
biosynthesis during the stage of active multiplication.
INDICATIONS AND CLINICAL USE
The treatment of infections due to susceptible gram negative organisms
(including strains of
shigellae, S. typhosa and other salmonellae, E. coli, H. influenzae,
and P. mirabilis) and susceptible
gram positive organisms (including streptococci, pneumococci, and
non-beta-lactamase
(penicillinase) producing staphylococci). Infections of the ear, nose,
throat and lower respiratory
tract.
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of
AMPICILLIN SODIUM FOR INJECTION and other antibacterial drugs,
AMPICILLIN SODIUM
FOR INJECTION should be used only to treat infections that are proven
or strongly suspected to be
caused by susceptible bacteria. When culture and susceptibility
information are available, they
should be considered in selecting or modifying antibacterial therapy.
In the absence of such data,
local epidemiology and susceptibility patterns may contribute to the
empiric selection of therapy.
CONTRAINDICATIONS
A history of allergic reactions to penicillin or cephalosporins.
WARNINGS
Before therapy, inquiry as to past penicillin or other allergies is
essential as reactions occur more
frequently in hypersens
                                
                                完全なドキュメントを読む
                                
                            

他の言語のドキュメント

製品の特徴 製品の特徴 フランス語 14-02-2020

この製品に関連するアラートを検索